comparemela.com

Latest Breaking News On - Javier cort - Page 6 : comparemela.com

Adaptive breast cancer therapy may bypass chemotherapy for 30% of patients

Chicago, Jun 3 (EFE).- Adapting breast cancer therapy based on patient response can eliminate the need for chemotherapy in a significant number of treatments that currently default to it, according to a study suggesting that a third of patients can successfully avoid this technique. The phase II PHERGain clinical trial, spearheaded by Spanish-American oncology research …

Comunidad autonoma de catalunaUnited statesUnited kingdomJavier cortAntonio llombart cussacInternational breast cancer centerAmerican society of clinical oncologyAmerican societyClinical oncologyPositron emission tomographyUniversidad europea de madrid

Chemo-Free Approach Works in Subset of Patients With HER2+ Early Breast Cancer

Impressive 3-year invasive DFS seen with adaptive response strategy using FDG-PET

United statesMike bassettJavier cortAmerican society of clinical oncologyCajal university hospitalAmerican societyClinical oncology

MEDSIR s PHERGain Trial Shows Potential for Chemotherapy-free Treatment of HER2-positive Early Breast Cancer

MEDSIR s PHERGain Trial Shows Potential for Chemotherapy-free Treatment of HER2-positive Early Breast Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAntonio llombart cussacJavier cortAmerican society of clinical oncologyClinical oncology

MEDSIR s PHERGain Trial Shows Potential for Chemotherapy-free Treatment of HER2-positive Early Breast Cancer

/PRNewswire/ MEDSIR announced today the positive results of the PHERGain trial. This study is the first to use an adaptive design that tailors treatment in.

United statesJavier cortAntonio llombart cussacAmerican society of clinical oncologyClinical oncology

Cancer battle shifts focus to less invasive methods, improved patient care

Washington, June 1 (EFE) – Chicago transforms into the hub of oncology research from Friday until Tuesday, as the American Society of Clinical Oncology (ASCO) is set to host its annual conference in the city once again, with a spotlight on less invasive treatments and enhancing the doctor-patient relationship. According to the organizers, this collaboration …

Mccormick placeUnited statesEric winerJavier cortAntonio llombart cussacJulie gralowMccormick place convention centerAmerican society of clinical oncologyWorld health organizationAmerican societyClinical oncologyVice presidentChief medical officerPositron emission tomography

vimarsana © 2020. All Rights Reserved.